Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation

被引:67
作者
Kim, Sanggu [1 ]
Ng, Wai Kiong [1 ]
Dong, Yuancai [1 ]
Das, Surajit [1 ]
Tan, Reginald B. H. [1 ,2 ]
机构
[1] Agcy Sci Technol & Res, Inst Chem & Engn Sci, Formulat Sci Grp Crystallizat & Particle Sci, Singapore 62783, Singapore
[2] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore
关键词
trans-Resveratrol nanoparticles; Temperature-controlled antisolvent precipitation; Freeze drying; Bioavailability; Saturation solubility; Dissolution rate; CANCER CHEMOPREVENTIVE ACTIVITY; DISSOLUTION RATE; CIS-RESVERATROL; DRUG PARTICLES; SIZE; MICRONIZATION; FORMULATION;
D O I
10.1016/j.jfoodeng.2011.07.034
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
In order to enhance the oral bioavailability, trans-resveratrol (t-RVT) nanoparticles were prepared by temperature-controlled antisolvent precipitation with the hydroxypropyl methylcellulose as the stabilizer. The mean particle size was reduced by decreasing the precipitation temperature, mainly due to the higher nucleation rate and slower growth rate. The freeze dried t-RVT nanoparticles were well reconstituted in aqueous solution maintaining a similar particle size and distribution in the nanosize range that is prior to freeze drying without the aid of cryoprotectants. The SEM images exhibited some aggregation of individual spherical nanosized particles. The FT-IR analysis confirmed that the molecular structure of t-RVT nanoparticles was not changed after the precipitation process. Furthermore, t-RVT nanoparticles showed significantly enhanced saturation solubility and dissolution rate by the decrease in particle size and degree of crystallinity when compared to the raw t-RVT. The combined results have demonstrated that this method can considerably enhance the bioavailability of t-RVT. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 35 条
  • [11] Minireview -: Biological effects of resveratrol
    Frémont, L
    [J]. LIFE SCIENCES, 2000, 66 (08) : 663 - 673
  • [12] BEYOND ALCOHOL - BEVERAGE CONSUMPTION AND CARDIOVASCULAR MORTALITY
    GOLDBERG, DM
    HAHN, SE
    PARKES, JG
    [J]. CLINICA CHIMICA ACTA, 1995, 237 (1-2) : 155 - 187
  • [13] Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
    Jang, MS
    Cai, EN
    Udeani, GO
    Slowing, KV
    Thomas, CF
    Beecher, CWW
    Fong, HHS
    Farnsworth, NR
    Kinghorn, AD
    Mehta, RG
    Moon, RC
    Pezzuto, JM
    [J]. SCIENCE, 1997, 275 (5297) : 218 - 220
  • [14] Nanosizing - Oral formulation development and biopharmaceutical evaluation
    Kesisoglou, Filippos
    Panmai, Santipharp
    Wu, Yunhui
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 631 - 644
  • [15] Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?
    Kopp, P
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (06) : 619 - 620
  • [16] Ostwald ripening of β-carotene nanoparticles
    Liu, Ying
    Kathan, Kendra
    Saad, Walid
    Prud'homme, Robert K.
    [J]. PHYSICAL REVIEW LETTERS, 2007, 98 (03)
  • [17] PARTICLE-SIZE REDUCTION FOR IMPROVEMENT OF ORAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS .1. ABSOLUTE ORAL BIOAVAILABILITY OF NANOCRYSTALLINE DANAZOL IN BEAGLE DOGS
    LIVERSIDGE, GG
    CUNDY, KC
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 125 (01) : 91 - 97
  • [18] Drug nanoparticles by antisolvent precipitation: Mixing energy versus surfactant stabilization
    Matteucci, Michal E.
    Hotze, Margaret A.
    Johnston, Keith P.
    Williams, Robert O., III
    [J]. LANGMUIR, 2006, 22 (21) : 8951 - 8959
  • [19] Apparent solubility of drugs in partially crystalline systems
    Mosharraf, M
    Nyström, C
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (06) : 603 - 622
  • [20] THE EFFECT OF PARTICLE-SIZE AND SHAPE ON THE SURFACE SPECIFIC DISSOLUTION RATE OF MICROSIZED PRACTICALLY INSOLUBLE DRUGS
    MOSHARRAF, M
    NYSTROM, C
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 122 (1-2) : 35 - 47